Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.

Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M.

Cell. 2001 Dec 14;107(6):789-800.

2.

RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling.

Noda M, Oh J, Takahashi R, Kondo S, Kitayama H, Takahashi C.

Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):167-75. Review.

PMID:
12784995
3.

The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.

Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H, Koyama F, Mukogawa T, Matsumoto H, Kondo S, Takahashi C, Noda M, Nakajima Y.

Clin Cancer Res. 2004 Aug 15;10(16):5572-9.

4.

Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.

Correa TC, Brohem CA, Winnischofer SM, da Silva Cardeal LB, Sasahara RM, Taboga SR, Sogayar MC, Maria-Engler SS.

J Cell Biochem. 2006 Sep 1;99(1):156-67.

PMID:
16791855
6.

The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors.

Echizenya M, Kondo S, Takahashi R, Oh J, Kawashima S, Kitayama H, Takahashi C, Noda M.

Oncogene. 2005 Sep 1;24(38):5850-7.

PMID:
16007210
7.

RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.

Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR, Seol SM, Han I.

J Orthop Res. 2007 May;25(5):696-702.

8.
9.

RECK negatively regulates matrix metalloproteinase-9 transcription.

Takagi S, Simizu S, Osada H.

Cancer Res. 2009 Feb 15;69(4):1502-8. doi: 10.1158/0008-5472.CAN-08-2635. Epub 2009 Feb 10.

10.

Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells.

Kondo S, Shukunami C, Morioka Y, Matsumoto N, Takahashi R, Oh J, Atsumi T, Umezawa A, Kudo A, Kitayama H, Hiraki Y, Noda M.

J Cell Sci. 2007 Mar 1;120(Pt 5):849-57. Epub 2007 Feb 13.

11.

RECKing MMP function: implications for cancer development.

Rhee JS, Coussens LM.

Trends Cell Biol. 2002 May;12(5):209-11. Review.

PMID:
12062160
12.

Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.

Liu LT, Chang HC, Chiang LC, Hung WC.

Cancer Res. 2003 Jun 15;63(12):3069-72.

13.

Rat forming incisor requires a rigorous ECM remodeling modulated by MMP/RECK balance.

Paiva KB, Zambuzzi WF, Accorsi-Mendonça T, Taga R, Nunes FD, Sogayar MC, Granjeiro JM.

J Mol Histol. 2009 Jun;40(3):201-7. doi: 10.1007/s10735-009-9231-4. Epub 2009 Oct 17.

PMID:
19838811
14.

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC.

BMC Cancer. 2009 Jan 14;9:20. doi: 10.1186/1471-2407-9-20.

15.

RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines.

Simizu S, Takagi S, Tamura Y, Osada H.

Cancer Res. 2005 Aug 15;65(16):7455-61.

16.

The ß1-integrin-dependent function of RECK in physiologic and tumor angiogenesis.

Miki T, Shamma A, Kitajima S, Takegami Y, Noda M, Nakashima Y, Watanabe K, Takahashi C.

Mol Cancer Res. 2010 May;8(5):665-76. doi: 10.1158/1541-7786.MCR-09-0351. Epub 2010 Apr 20.

17.

Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice.

Oh J, Takahashi R, Adachi E, Kondo S, Kuratomi S, Noma A, Alexander DB, Motoda H, Okada A, Seiki M, Itoh T, Itohara S, Takahashi C, Noda M.

Oncogene. 2004 Jun 24;23(29):5041-8.

PMID:
15064723
18.

Transcriptional control of the RECK metastasis/angiogenesis suppressor gene.

Sasahara RM, Brochado SM, Takahashi C, Oh J, Maria-Engler SS, Granjeiro JM, Noda M, Sogayar MC.

Cancer Detect Prev. 2002;26(6):435-43. Review.

PMID:
12507228
19.

Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.

Park HJ, Lee HJ, Min HY, Chung HJ, Suh ME, Park-Choo HY, Kim C, Kim HJ, Seo EK, Lee SK.

Eur J Pharmacol. 2005 Dec 19;527(1-3):31-6. Epub 2005 Nov 23.

PMID:
16309669
20.

Supplemental Content

Support Center